Radermacher P - Search Results

1

Opportunities for the repurposing of PARP inhibitors for the therapy of non-oncological diseases.

Berger NA, Besson VC, Boulares AH, Bürkle A, Chiarugi A, Clark RS, Curtin NJ, Cuzzocrea S, Dawson TM, Dawson VL, Haskó G, Liaudet L, Moroni F, Pacher P, Radermacher P, Salzman AL, Snyder SH, Soriano FG, Strosznajder RP, Sümegi B, Swanson RA, Szabo C. Berger NA, et al. Among authors: radermacher p. Br J Pharmacol. 2018 Jan;175(2):192-222. doi: 10.1111/bph.13748. Epub 2017 Mar 26. Br J Pharmacol. 2018. PMID: 28213892 Free PMC article. Review.

2

The world according to poly(ADP-ribose) polymerase (PARP)--update 2006.

Barth E, Radermacher P, Szabó C. Barth E, et al. Among authors: radermacher p. Intensive Care Med. 2006 Oct;32(10):1470-4. doi: 10.1007/s00134-006-0336-x. Epub 2006 Aug 23. Intensive Care Med. 2006. PMID: 16927074 No abstract available.

3

Regulation of mitochondrial bioenergetic function by hydrogen sulfide. Part II. Pathophysiological and therapeutic aspects.

Módis K, Bos EM, Calzia E, van Goor H, Coletta C, Papapetropoulos A, Hellmich MR, Radermacher P, Bouillaud F, Szabo C. Módis K, et al. Among authors: radermacher p. Br J Pharmacol. 2014 Apr;171(8):2123-46. doi: 10.1111/bph.12368. Br J Pharmacol. 2014. PMID: 23991749 Free PMC article. Review.

4

To the Editor.

Radermacher P, Calzia E, McCook O, Wachter U, Szabo C. Radermacher P, et al. Shock. 2021 Jan 1;55(1):138-139. doi: 10.1097/SHK.0000000000001602. Shock. 2021. PMID: 32590692 Free PMC article. No abstract available.

5

H2S as a Therapeutic Adjuvant Against COVID-19: Why and How?

Datzmann T, Merz T, McCook O, Szabo C, Radermacher P. Datzmann T, et al. Among authors: radermacher p. Shock. 2021 Nov 1;56(5):865-867. doi: 10.1097/SHK.0000000000001723. Shock. 2021. PMID: 33443365 Free PMC article. No abstract available.

6

The parp-1 inhibitor ino-1001 facilitates hemodynamic stabilization without affecting DNA repair in porcine thoracic aortic cross-clamping-induced ischemia/reperfusion.

Hauser B, Gröger M, Ehrmann U, Albicini M, Brückner UB, Schelzig H, Venkatesh B, Li H, Szabó C, Speit G, Radermacher P, Kick J. Hauser B, et al. Among authors: radermacher p. Shock. 2006 Jun;25(6):633-40. doi: 10.1097/01.shk.0000209561.61951.2e. Shock. 2006. PMID: 16721272

7

Systemic and hepatosplanchnic hemodynamic and metabolic effects of the PARP inhibitor PJ34 during hyperdynamic porcine endotoxemia.

Iványi Z, Hauser B, Pittner A, Asfar P, Vassilev D, Nalos M, Altherr J, Brückner UB, Szabó C, Radermacher P, Fröba G. Iványi Z, et al. Among authors: radermacher p. Shock. 2003 May;19(5):415-21. doi: 10.1097/01.shk.0000048904.46342.22. Shock. 2003. PMID: 12744483

8

Hyperbaric oxygen and sepsis: time to recognize.

Muth CM, Radermacher P, Cuzzocrea S. Muth CM, et al. Among authors: radermacher p. Intensive Care Med. 2005 Sep;31(9):1150-2. doi: 10.1007/s00134-005-2700-7. Epub 2005 Jul 21. Intensive Care Med. 2005. PMID: 16034623 No abstract available.

9

Impact of hyperglycemia on cystathionine-γ-lyase expression during resuscitated murine septic shock.

Merz T, Vogt JA, Wachter U, Calzia E, Szabo C, Wang R, Radermacher P, McCook O. Merz T, et al. Among authors: radermacher p. Intensive Care Med Exp. 2017 Dec;5(1):30. doi: 10.1186/s40635-017-0140-7. Epub 2017 Jun 14. Intensive Care Med Exp. 2017. PMID: 28616781 Free PMC article.

10

ΔMST and the Regulation of Cardiac CSE and OTR Expression in Trauma and Hemorrhage.

Trautwein B, Merz T, Denoix N, Szabo C, Calzia E, Radermacher P, McCook O. Trautwein B, et al. Among authors: radermacher p. Antioxidants (Basel). 2021 Feb 3;10(2):233. doi: 10.3390/antiox10020233. Antioxidants (Basel). 2021. PMID: 33546491 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

451 results

Search Page